GlassScriptPhysician profile
Heather Weissman
NPI 1457641441
$35,718.53
in general payments reported to CMS, 2019-2025
26 companies · $7,476 in 2025
The $7,476 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,276 · 2020: $613 · 2021: $518 · 2022: $6,782 · 2023: $16K · 2024: $1,969 · 2025: $7,476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $6,879 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Consulting Fee: $1,400 · Travel and Lodging: $876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,875.00 |
| Food and Beverage | $6,878.85 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Consulting Fee | $1,400.00 |
| Travel and Lodging | $875.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $23,046.26 | 2020-2025 | Tearcare System, Omni Surgical System, Sion Surgical Instrument |
| Bausch & Lomb Americas INC. | $2,883.47 | 2022-2025 | Xiidra, Miebo, Envista Mx60 Iol |
| Alcon Vision LLC | $1,869.03 | 2019-2025 | Clareon, Unity, Clareon Panoptix Pro |
| Glaukos Corporation | $1,795.84 | 2019-2025 | Idosetr, Istent Trabecular Micro-Bypass System Model Is3, Istent Infinite |
| Shire North American Group INC | $1,540.95 | 2019 | |
| Sun Pharmaceutical Industries INC. | $1,006.19 | 2019-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $373.26 | 2019-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $352.54 | 2019-2025 | Tecnis Iol, Tecnis Iol, Tecnis Simplicity |
| Allergan, INC. | $318.65 | 2019-2022 | |
| Oyster Point Pharma, INC. | $314.64 | 2022-2025 | Tyrvaya |
| Rxsight INC | $308.81 | 2021-2025 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Biotissue Holdings INC. | $291.32 | 2019-2023 | |
| Dompe US, INC. | $257.47 | 2019-2025 | Oxervate |
| Eyepoint US, INC. | $250.00 | 2019 | |
| Kala Pharmaceuticals, INC. | $191.36 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $159.49 | 2024-2025 | Vevye |
| Abbvie INC. | $148.76 | 2022-2024 | |
| Genentech USA, INC. | $130.18 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $127.98 | 2022 | |
| Horizon Therapeutics Plc | $125.00 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $75.04 | 2019-2020 | |
| Akorn, INC. | $55.23 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $32.74 | 2025 | Xdemvy |
| Amgen INC. | $25.00 | 2024 | Tepezza |
| Ocular Therapeutix, INC. | $22.08 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Weissman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.